Related Experiment Video
Updated: Jul 30, 2025

Intratracheal Instillation of Stem Cells in Term Neonatal Rats
Published on: May 4, 2020
Corticosteroids treatment for pediatric acute respiratory syndrome: A critical review
1From the Department of Pediatric, Pediatric Critical Care Unit, Faculty of Medicine, King Abdulaziz University, Jeddah, Kingdom of Saudi Arabia.
Insights
Pediatric Acute Respiratory Distress Syndrome (PARDS) is a severe ICU condition. This review examines steroid use in PARDS, highlighting current developments and management strategies.
Area of Science:
- Pediatric critical care medicine
- Pulmonology
- Intensive care medicine
Background:
- Respiratory conditions account for 25% of pediatric consultations, with asthma being 10%.
- Pediatric Acute Respiratory Distress Syndrome (PARDS) is a rare but highly lethal condition in pediatric intensive care units.
- Historically, adult ARDS guidelines were applied to PARDS before the PALICC established new criteria.
Conclusions:
- Further research is needed to clarify the role of steroids in pediatric ARDS treatment.
- Adherence to PALICC guidelines is crucial for optimal PARDS management.
- Despite its rarity, PARDS requires specialized and evolving treatment protocols.
Abstract:
Approximately 25% of all pediatric consultations are due to respiratory conditions, 10% of which are for asthma. Regarding prevalence, bronchiolitis, acute bronchitis, and respiratory infections are other leading pediatric respiratory illnesses. Compared to the aforementioned diseases, pediatric acute respiratory distress syndrome (PARDS) is rare but lethal in the Intensive Care Unit patients. According to global studies, the mortality in PARDS ranges from 13.3% to 60.7%. Before the Pediatric Acute Lung Injury Consensus Conference (PALICC), adult acute respiratory distress syndrome (ARDS) management guidelines were used for PARDS. The PALICC set new criteria to identify PARDS with a different treatment and management approach. Steroids have been used to treat ARDS in some cases, although their effectiveness in treating pediatric patients is highly debated in the scientific community. This review examines steroid use in treating PARDS, emphasizes current developments in the field, and gives a broad overview of PARDS management.
More Related Videos
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
COPD: Management Using Bronchodilators and Corticosteroids
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Acute Respiratory Failure-II
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:

